investerare
Med en snabbt växande verksamhet i Europa och planer på en framtida lansering i USA är Sedana Medical väl positionerat för framtiden.
Vi är på god väg mot vår vision att göra inhalationssedering till en standardbehandling inom intensivvården.
- Johan Spetz
- CFO och chef för Investor Relations
- ir@sedanamedical.com
Aktie
Pressmeddelanden
2026
2026-04-14 18:00
Sedana Medical publishes its Annual Report for 2025
Sedana Medical AB’s (publ) Annual Report describes important events and financial information for 2025, as well as the progress the company has made...
2026-04-10 08:00
Invitation to presentation of Sedana Medical’s interim report for the first quarter 2026
Sedana Medical AB (publ) plans to present its interim report for the first quarter of 2026 on Thursday April 23 at 13:30 CET. According to the financial...
Sedana Medical AB (publ) today reports that the first patient has been treated in the company’s Early Access Program (EAP) in the U.S. The program...
Finansiella rapporter
Finansiell kalender
Senaste presentationen
Sedana Medical presentation vid Jefferies London Healthcare Conference 18 november 2021
18 november 2021 00:00